As of January 2025 Biohaven Pharmaceutical has a market cap of A$6.12 Billion. This makes Biohaven Pharmaceutical the world's 3165th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 29th, 2025 the market cap of Biohaven Pharmaceutical was reported to be: